News

iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

  • LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022.
    08/31/2022

iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q2 2022 Results - Earnings Call Transcript

  • iSpecimen Inc. (NASDAQ:ISPC ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Allison Soss - Senior Vice President of Investor Relations Christopher Ianelli - President & Chief Executive Officer Jill Mullan - Chief Operating Officer Tracy Curley - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton James Lieberman - Revere Securities Operator Good day, everyone and welcome to iSpecimen Second Quarter 2022 Conference Call. [Operator Instructions] A replay of today's call will be available on the Investor Relations section of iSpecimen's website and will remain posted there for the next 30 days.
    08/08/2022
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

iSpecimen Inc. (ISPC) can hold. Click on Rating Page for detail.

The price of iSpecimen Inc. (ISPC) is 1.68 and it was updated on 2022-10-06 13:00:40.

Currently iSpecimen Inc. (ISPC) is in undervalued.

News
    
News

iSpecimen to Report Second Quarter 2022 Results on August 4, 2022

  • LEXINGTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2022, before the markets open on Thursday, August 4, 2022.
    Thu, Jul. 21, 2022

Why iSpecimen Shares Are Gaining Today?

  • iSpecimen Inc (NASDAQ: ISPC) has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research. The new suppliers include a cancer-focused biobank in the U.S., which contains a differentiated range of pre-.
    Thu, Jul. 07, 2022

iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q1 2022 Results - Earnings Call Transcript

  • iSpecimen Inc. (NASDAQ:ISPC ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Allison Soss - Investor Relations Christopher Ianelli - Chief Executive Officer and President Tracy Curley - Chief Financial Officer Jill Mullan - Chief Operating Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton Operator Good day, everyone, and welcome to iSpecimen's First Quarter 2022 Conference Call. [Operator Instructions] This conference is being recorded.
    Sat, May. 14, 2022

iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript

  • iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript
    Thu, Feb. 17, 2022

iSpecimen to Participate in the Aegis Virtual Conference on February 24, 2022

  • LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Aegis Capital Corp. Virtual Conference to be held virtually on February 23-25, 2022.
    Thu, Feb. 10, 2022
Transcripts
Transcipts Data
SEC Filings
SEC Filings

iSpecimen Inc. (ISPC) - SC 13G

  • SEC Filings
  • 09/27/2022

iSpecimen Inc. (ISPC) - EFFECT

  • SEC Filings
  • 08/08/2022

iSpecimen Inc. (ISPC) - 424B3

  • SEC Filings
  • 08/05/2022

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 08/03/2022

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 08/03/2022

iSpecimen Inc. (ISPC) - S-3

  • SEC Filings
  • 07/28/2022

iSpecimen Inc. (ISPC) - EFFECT

  • SEC Filings
  • 07/13/2022

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 07/08/2022

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 07/08/2022

iSpecimen Inc. (ISPC) - S-3

  • SEC Filings
  • 07/01/2022

iSpecimen Inc. (ISPC) - EFFECT

  • SEC Filings
  • 06/07/2022

iSpecimen Inc. (ISPC) - 424B3

  • SEC Filings
  • 06/07/2022

iSpecimen Inc. (ISPC) - POS AM

  • SEC Filings
  • 05/26/2022

iSpecimen Inc. (ISPC) - DEFA14A

  • SEC Filings
  • 04/14/2022

iSpecimen Inc. (ISPC) - DEF 14A

  • SEC Filings
  • 04/14/2022

iSpecimen Inc. (ISPC) - PRE 14A

  • SEC Filings
  • 03/30/2022

iSpecimen Inc. (ISPC) - SC 13G/A

  • SEC Filings
  • 02/14/2022

iSpecimen Inc. (ISPC) - SC 13G

  • SEC Filings
  • 02/14/2022

iSpecimen Inc. (ISPC) - SC 13G

  • SEC Filings
  • 02/07/2022

iSpecimen Inc. (ISPC) - SC 13G

  • SEC Filings
  • 01/24/2022

iSpecimen Inc. (ISPC) - EFFECT

  • SEC Filings
  • 12/27/2021

iSpecimen Inc. (ISPC) - 424B3

  • SEC Filings
  • 12/23/2021

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 12/21/2021

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 12/21/2021

iSpecimen Inc. (ISPC) - S-8

  • SEC Filings
  • 12/16/2021

iSpecimen Inc. (ISPC) - S-1

  • SEC Filings
  • 12/14/2021

iSpecimen Inc. (ISPC) - D

  • SEC Filings
  • 12/09/2021

iSpecimen Inc. (ISPC) - SC 13G

  • SEC Filings
  • 07/09/2021

iSpecimen Inc. (ISPC) - 424B4

  • SEC Filings
  • 06/21/2021

iSpecimen Inc. (ISPC) - EFFECT

  • SEC Filings
  • 06/16/2021

iSpecimen Inc. (ISPC) - CERT

  • SEC Filings
  • 06/16/2021

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 06/14/2021

iSpecimen Inc. (ISPC) - 8-A12B

  • SEC Filings
  • 06/14/2021

iSpecimen Inc. (ISPC) - FWP

  • SEC Filings
  • 05/28/2021

iSpecimen Inc. (ISPC) - S-1/A

  • SEC Filings
  • 05/27/2021

iSpecimen Inc. (ISPC) - S-1/A

  • SEC Filings
  • 05/13/2021

iSpecimen Inc. (ISPC) - S-1/A

  • SEC Filings
  • 04/27/2021

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 04/27/2021

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 04/26/2021

iSpecimen Inc. (ISPC) - S-1/A

  • SEC Filings
  • 04/02/2021

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 04/02/2021

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 02/01/2021

iSpecimen Inc. (ISPC) - S-1/A

  • SEC Filings
  • 01/20/2021

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 01/20/2021

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 01/15/2021

iSpecimen Inc. (ISPC) - S-1/A

  • SEC Filings
  • 12/31/2020

iSpecimen Inc. (ISPC) - CORRESP

  • SEC Filings
  • 12/31/2020

iSpecimen Inc. (ISPC) - UPLOAD

  • SEC Filings
  • 12/14/2020

iSpecimen Inc. (ISPC) - S-1

  • SEC Filings
  • 11/19/2020

iSpecimen Inc. (ISPC) - D

  • SEC Filings
  • 08/16/2018

iSpecimen Inc. (ISPC) - D

  • SEC Filings
  • 03/29/2017

iSpecimen Inc. (ISPC) - D

  • SEC Filings
  • 09/05/2014

iSpecimen Inc. (ISPC) - D

  • SEC Filings
  • 09/25/2012
Press Releases
StockPrice Release
More Headlines
News

iSpecimen to Report Fourth Quarter and Full Year 2021 Results on February 17, 2022

  • LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2021, before the markets open on Thursday, February 17, 2022.
  • 02/03/2022

iSpecimen Stock (ISPC): Why The Price Went Up Today

  • The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 4% during intraday trading today. This is why it happened.
  • 01/13/2022

Why ISpecimen Shares Are Surging Higher Today

  • ISpecimen Inc (NASDAQ: ISPC) is trading higher Thursday after the company announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research. ISpecimen said the reference lab has the capacity to sequence hundreds of COVID-19 positive swabs per week.
  • 01/13/2022

ISPC Stock: What Is Going on With Little-Known iSpecimen Today?

  • ISPC stock received a $20 price target from Craig-Hallum today. This comes after iSpecimen made several developments during 2021.
  • 01/04/2022

See why Craig-Hallum Is Bullish On iSpecimen

  • Craig-Hallum initiated coverage of iSpecimen Inc (NASDAQ:ISPC) with a Buy rating and $20 price target.  "Much the way Amazon has become the go-to platform for buyers and sellers of consumer goods," the analyst believes iSpecimen can become the go-to platform for human biospecimens, writes analyst Matthew Hewitt.
  • 01/04/2022

5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again

  • Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile examples of short squeezes earlier this year.
  • 12/20/2021

iSpecimen (ISPC) Stock: Why The Price Increased Today

  • The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 7% pre-market today. This is why it happened.
  • 11/30/2021

iSpecimen (ISPC) Stock: Why The Price Fell Today

  • The stock price of iSpecimen Inc (NASDAQ: ISPC) fell by over 6% pre-market today. This is why it happened.
  • 11/29/2021

iSpecimen (ISPC) Stock: Why The Price Surged Today

  • The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 65% pre-market today. This is why it happened.
  • 11/26/2021

Here is why iSpecimen is up 50% today

  • iSpecimen Inc (NASDAQ: ISPC) is a human biospecimens marketplace that operates online. It announced that private companies and the U.S government had contracted it to be a part of the new advanced Covid-19 research efforts providing the process with human biospecimens.
  • 11/23/2021

Why ISpecimen Shares Continue To Move Higher Today

  • ISpecimen Inc (NASDAQ: ISPC) is trading higher Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes and testing validity among multiple population segments. ISpecimen's work on COVID-19 began immediately after the outbreak last year when it began helping researchers monitor antibody development for possible guidance on immunity.
  • 11/23/2021

iSpecimen (ISPC) Stock: Why The Price Surged Today

  • The stock price of iSpecimen Inc. (NASDAQ: ISPC) increased by over 85% pre-market today. This is why it happened.
  • 11/23/2021

3 Hot Penny Stocks to Watch That Exploded Today, One Up 93%

  • Why these three penny stocks exploded today The post 3 Hot Penny Stocks to Watch That Exploded Today, One Up 93% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
  • 11/22/2021

PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today

  • PainReform (PRFX) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. The post PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today appeared first on InvestorPlace.
  • 11/22/2021

ISPC Stock: The Covid-19 Research News That Has iSpecimen Shares Skyrocketing 100% Today

  • iSpecimen (ISPC) stock is up Monday after announcing partnerships with the U.S. Government and private researchers for Covid-19 research. The post ISPC Stock: The Covid-19 Research News That Has iSpecimen Shares Skyrocketing 100% Today appeared first on InvestorPlace.
  • 11/22/2021

iSpecimen Stock Rallies On Supply Pact Of Human Biospecimens For COVID-19 Research

  • iSpecimen Inc (NASDAQ: ISPC), an online marketplace for human biospecimens, has been contracted to support new advanced research on COVID-19.  In the last ten months, the Company has partnered with multiple research and health care organizations on diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.
  • 11/22/2021

iSpecimen (ISPC) Stock: Why The Price Surged Today

  • The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 135% pre-market today. This is why it happened.
  • 11/22/2021

iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q3 2021 Results - Earnings Call Transcript

  • iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q3 2021 Results - Earnings Call Transcript
  • 11/06/2021

iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021

  • LEXINGTON, Mass., Sept. 1, 2021 /PRNewswire/ --  iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C.
  • 09/01/2021

iSpecimen Expands Human Biospecimen Offerings for Cancer Researchers

  • LEXINGTON, Mass., Aug. 18, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens  ("iSpecimen" or the "Company"), today announced it has grown its cancer-related supplier network despite lockdowns, slowdowns, and sustained concern around the COVID-19 pandemic.
  • 08/18/2021

iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TV

  • LEXINGTON, Mass., Aug. 12, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that an interview with its CEO and President, Dr. Christopher Ianelli, will air on The RedChip Money Report® on Bloomberg TV, at 7 p.m.
  • 08/12/2021

iSpecimen Reports Second Quarter 2021 Financial Results

  • LEXINGTON, Mass., Aug. 10, 2021 /PRNewswire/ --  iSpecimen Inc.  (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today reported its financial results for the three-month period ended June 30, 2021.
  • 08/10/2021

iSpecimen Launches Enhanced Custom Collection Service

  • LEXINGTON, Mass., July 29, 2021 /PRNewswire/ --  iSpecimen   Inc.  (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that it has enhanced its custom biofluids collection service to offer life sciences organizations faster delivery of urgently needed research samples.
  • 07/29/2021

iSpecimen to Report Second Quarter 2021 Results on August 10, 2021

  • LEXINGTON, Mass., July 27, 2021 /PRNewswire/ --  iSpecimen Inc.  (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its financial results for the second quarter ended June 30, 2021, before the market open on Tuesday, August 10, 2021.
  • 07/27/2021

iSpecimen: High Growth Marketplace At A Discount

  • iSpecimen: High Growth Marketplace At A Discount
  • 07/07/2021

iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering

  • LEXINGTON, Mass., July 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of the issuance of an additional 337,500 shares of its common stock pursuant to the full exercise of the underwriters' over-allotment option in connection with the Company's initial public offering (the "IPO").
  • 07/01/2021

iSpecimen Announces Closing of Initial Public Offering

  • LEXINGTON, Mass., June 21, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of its previously announced initial public offering of 2,250,000 shares of its common stock at a price of $8.00 per share, for gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and offering expenses.
  • 06/21/2021

3 Biotechs Plus a Mortgage Lender Go Public Today

  • The companies are Verve Therapeutics, Lyell Immunopharma, iSpecimen and Angel Oak Mortgage.
  • 06/17/2021
Unlock
ISPC Ratings Summary
ISPC Quant Ranking